Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
23.76B | 23.73B | 22.56B | 20.81B | 19.20B | 29.15B | Gross Profit |
11.53B | 11.25B | 10.81B | 9.72B | 7.91B | 12.50B | EBIT |
406.00M | 518.00M | 293.00M | 159.00M | -2.18B | -727.00M | EBITDA |
848.50M | 1.00B | 546.00M | 376.00M | -3.59B | -431.00M | Net Income Common Stockholders |
425.00M | 427.00M | 491.00M | 138.00M | -4.42B | -1.30B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.62B | 5.20B | 6.73B | 7.97B | 6.89B | 3.29B | Total Assets |
25.81B | 27.80B | 27.50B | 27.38B | 27.87B | 28.70B | Total Debt |
9.32B | 10.59B | 10.55B | 11.40B | 11.93B | 6.10B | Net Debt |
5.70B | 5.39B | 3.82B | 3.43B | 5.04B | 2.81B | Total Liabilities |
13.46B | 15.35B | 16.54B | 17.10B | 17.59B | 14.34B | Stockholders Equity |
12.35B | 12.42B | 10.93B | 10.25B | 10.26B | 14.33B |
Cash Flow | Free Cash Flow | ||||
0.00 | -1.52B | -821.00M | 1.36B | -2.69B | -799.00M | Operating Cash Flow |
0.00 | -1.05B | 102.00M | 1.54B | -2.50B | -435.00M | Investing Cash Flow |
0.00 | -296.00M | -485.00M | 45.00M | 445.00M | -393.00M | Financing Cash Flow |
0.00 | -186.00M | -884.00M | -593.00M | 5.67B | 411.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥61.01B | 13.80 | 2.92% | 10.32% | 35.08% | ||
74 Outperform | ¥122.75B | 12.85 | 5.13% | 4.38% | 10.39% | ||
73 Outperform | €75.95B | 8.93 | 10.13% | 4.80% | 9.90% | 28.80% | |
65 Neutral | €101.83B | 11.05 | 5.34% | 6.35% | 1.72% | 15.08% | |
64 Neutral | ¥367.59B | 11.30 | 4.20% | 2.84% | 1.27% | -19.36% | |
61 Neutral | $6.92B | 11.84 | 3.00% | 3.95% | 2.60% | -21.94% | |
60 Neutral | ¥8.15B | 11.66 | 2.97% | 3.57% | 214.31% |